|
In the middle of the trial set-up we are pleased to announce that we are expanding our recruitment network to include more high-calibre recruiting centres in Belgium and Germany as well as one in Austria! Please have a look at the newly updated webpage with details of all recruiting centres involved in EURO SHOCK.
0 Comments
It is with great pleasure that we welcome the new Senior Trial Manager of EURO SHOCK Ms. Saeeda Bashir to the team.
Based at the University Hospitals of Leicester, Ms. Saeeda Bashir will be responsible for overseeing the management of the EURO SHOCK multi-centre International Randomised Trial involving seven European Union member states and multiple European participating sites. With a track-record of successfully developing and delivering of multi-centre clinical trials and her experience in providing leadership, project and trial management expertise to maintain the smooth and effective running of the clinical trial, we are confident that she will contribute to deliver this trial in accordance with the study protocols, ethics and regulatory approvals, SOPs, GCP principles, EU Directives and UK legislation to the highest level of research governance. On behalf of all partners in EURO SHOCK, we are looking forward to welcome Ms. Bashir to the team and looking forward to working with her. The new EURO SHOCK study is to receive € 6.5 million from the EU, to assess a new procedure of treatment approach for patients suffering cardiogenic shock. The project unites the foremost physicians in cardio-vascular medicine from across Europe, and is determined to become a bench-mark study on one of the few last challenges in this field. The ambition for EURO SHOCK is nothing less than to reduce the mortality associated with cardiogenic shock – a life threatening condition following a severe coronary heart attack.
Cardio-vascular diseases are responsible for more than 4 million deaths across Europe every year. Overall this type of disease is estimated to cost the European economy € 210 billion a year. Acute myocardial infarction, also more commonly known as heart attacks, evolve in about 10% of all cases into cardiogenic shock (in Europe 60.000-70.000 cases per year) with a 50% mortality rate in the first 30 days. This number is even higher in women and elderly patient groups. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
March 2020
Categories |
RSS Feed
